Agenus to Acquire Antibody Manufacturing Capability, Expands Antibody Discovery and adds Cell Line Development Capabilities with Three Separate Transactions
Go back to Agenus to Acquire Antibody Manufacturing Capability, Expands Antibody Discovery and adds Cell Line Development Capabilities with Three Separate Transactions| AGENUS (NASDAQ: AGEN) | Delayed: 3.07 +0.03 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $7.49 | |||
| Open | $2.99 | 52 Week Low | $2.61 | |||
| Day High | $3.18 | P/E | N/A | |||
| Day Low | $2.99 | EPS | $-1.10 | |||
| Volume | 438,570 | |||||
| XOMA (NASDAQ: XOMA) | Delayed: 41.95 -0.05 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.00 | 52 Week High | $7.33 | |||
| Open | $41.09 | 52 Week Low | $0.34 | |||
| Day High | $42.15 | P/E | N/A | |||
| Day Low | $40.76 | EPS | $-0.73 | |||
| Volume | 134,937 | |||||

